Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Open-angle Glaucoma (POAG) Patient”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05279716
What this trial is testing

Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl

Who this might be right for
Normal Tension GlaucomaPrimary Open-angle GlaucomaGlaucoma, Suspect+1 more
Santen Pharmaceutical Asia Pte. Ltd. 150
Not applicableStudy completedNCT01058278
What this trial is testing

Impact Post-operative Treatment on Intraocular Pressure Post-SLT on Patients With Primary Open-angle Glaucoma

Who this might be right for
GlaucomaInflammatory Response
CHU de Quebec-Universite Laval 67
Post-approval studies (Phase 4)Study completedNCT01978015
What this trial is testing

Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG

Who this might be right for
Uveitis, AnteriorCystoid Macular Edema
University of Campinas, Brazil 69
Testing effectiveness (Phase 2)UnknownNCT03067415
What this trial is testing

Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily

Who this might be right for
Glaucoma, Primary Open AngleOcular Hypertension
Chong Kun Dang Pharmaceutical 98
Not applicableStudy completedNCT01085357
What this trial is testing

Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery

Who this might be right for
Primary Open Angle Glaucoma (POAG)Cataract
Transcend Medical, Inc. 897
Large-scale testing (Phase 3)Study completedNCT01342081
What this trial is testing

DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd. 489
Not applicableWithdrawnNCT01495299
What this trial is testing

24-hour IOP Fluctuation Profile Recorded With SENSIMED Triggerfish in Primary Open-angle Glaucoma (POAG) Patients After Cataract Surgery

Who this might be right for
Glaucoma
University of California, San Diego
Not applicableStudy completedNCT01767753
What this trial is testing

IOP Fluctuations in Patients With Primary Open-angle Glaucoma, Before and After Selective Laser Trabeculoplasty

Who this might be right for
Primary Open Angle GlaucomaPigmentary GlaucomaPseudoexfoliative Glaucoma
Sensimed AG 23
Not applicableStudy completedNCT03931317
What this trial is testing

Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity

Who this might be right for
OAG - Open-Angle GlaucomaOHT - Ocular Hypertension
University of California, San Diego 70
Not applicableLooking for participantsNCT07390890
What this trial is testing

DSLT for Reducing Medication in Glaucoma

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
The Eye Institute of West Florida 60
Not applicableStudy completedNCT01637246
What this trial is testing

Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 4,385
Not applicableUnknownNCT02679482
What this trial is testing

Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma

Who this might be right for
Glaucoma, Open-AngleGlaucoma, Primary Open AngleExfoliation Glaucoma+1 more
Fundación Oftalmológica Nacional 36
Post-approval studies (Phase 4)UnknownNCT05606796
What this trial is testing

Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients, at Guinness Eye Centre, Lagos.

Who this might be right for
Effect of Drug
Uzoma Chinyei Joan 76
Large-scale testing (Phase 3)Study completedNCT05973318
What this trial is testing

Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt® Eye Drops, 20 mg/mL + 5 mg/mL

Who this might be right for
Primary Open Angle Glaucoma of Both Eyes
Jadran Galenski laboratorij d.d. 110
Post-approval studies (Phase 4)Study completedNCT04654611
What this trial is testing

Tafluprost Preservative Free Switch Study

Who this might be right for
GlaucomaPrimary Open Angle GlaucomaOcular Hypertension
Tun Hussein Onn National Eye Hospital 28
Not applicableUnknownNCT06214676
What this trial is testing

OCTA in Patients With Primary Open-angle Glaucoma

Who this might be right for
Open Angle Glaucoma
Assiut University 30
Not applicableLooking for participantsNCT07358650
What this trial is testing

Clinical Study Evaluating the Safety and Performance of the MIST Device for Intraocular Pressure Reduction in Patients With Primary Open-Angle Glaucoma

Who this might be right for
Primary Open Angle Glaucoma
Hexiris Inc 25
Early research (Phase 1)Study completedNCT00515424
What this trial is testing

Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension

Who this might be right for
GlaucomaOcular Hypertension
Novartis 90
Not applicableUnknownNCT00773877
What this trial is testing

Comparison of Retinal Nerve Fiber Layer (RNFL) Thickness Measurements by Time-Domain and Spectral-Domain OCT In Glaucoma Patients

Who this might be right for
Primary Open Angle Glaucoma
Yonsei University 400
Not applicableStudy completedNCT00706927
What this trial is testing

Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
RetinaOcular Physiology
Medical University of Vienna 16
Next Page